申请人:Andreotti Daniele
公开号:US20090170902A1
公开(公告)日:2009-07-02
Compounds of formula (I), salts and solvates thereof are provided:
wherein Ar is selected from phenyl, pyridyl, furanyl and thienyl, each optionally substituted with one or more groups Y; and each Y group is independently selected from the group consisting of: halo, C
1-4
alkyl, haloC
1-4
alkyl, C
1-4
alkoxy, cyano, C(O)C
1-4
alkyl, NHSO
2
C
1-4
alkyl, NMeSO
2
C
1-4
alkyl, NHCOC
1-4
alkyl, NMeCOC
1-4
alkyl, SOC
1-4
alkyl, SO
2
C
1-4
alkyl, and CO
2
C
1-4
alkyl, or two Y groups together form a cyclic group —O(CH
2
)O—. Processes for preparation, and uses thereof in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.
提供化学式(I)的化合物、盐和溶剂化物:其中Ar从苯基、吡啶基、呋喃基和噻吩基中选择,每个基团Y可以选择以下组中的任意一种:卤素、C1-4烷基、卤代C1-4烷基、C1-4烷氧基、氰基、C(O)C1-4烷基、NHSO2C1-4烷基、NMeSO2C1-4烷基、NHCOC1-4烷基、NMeCOC1-4烷基、SOC1-4烷基、SO2C1-4烷基和CO2C1-4烷基,或两个Y基团一起形成一个环状基团- O(CH2)O-。还公开了制备过程以及在治疗由谷氨酸受体功能减少或失衡引起的疾病或症状,如精神分裂症或认知障碍中的用途。